Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Macrocyclic Polypeptide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113583088A details novel cyclic peptide synthesis targeting STRN3 for gastric cancer, offering improved stability and cell permeability for pharmaceutical manufacturing.